BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Location
Sunnyvale, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 83% % 29%
Debt-to-equity 24257% %
Return On Equity -58897% % -5984%
Return On Assets -242% % -16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,612,734 shares 132%
Common Stock, Shares, Outstanding 10,608,734 shares 135%
Entity Public Float $5,600,000 USD -88%
Common Stock, Value, Issued $11,000 USD 120%
Weighted Average Number of Shares Outstanding, Basic 6,277,848 shares 122%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $5,249,000 USD 27%
Costs and Expenses $8,586,000 USD 9.6%
Operating Income (Loss) $8,586,000 USD -11%
Nonoperating Income (Expense) $46,000 USD 9.5%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $8,540,000 USD -11%
Earnings Per Share, Basic -1 USD/shares 80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,287,000 USD 7.2%
Accounts Receivable, after Allowance for Credit Loss, Current $10,000 USD 0%
Assets, Current $5,365,000 USD 6.1%
Property, Plant and Equipment, Net $13,000 USD -72%
Operating Lease, Right-of-Use Asset $599,000 USD -40%
Other Assets, Noncurrent $171,000 USD 0%
Assets $6,148,000 USD -1.9%
Accounts Payable, Current $1,080,000 USD 90%
Accrued Liabilities, Current $108,000 USD 286%
Liabilities, Current $3,310,000 USD 17%
Operating Lease, Liability, Noncurrent $211,000 USD -69%
Liabilities $3,521,000 USD 0.2%
Retained Earnings (Accumulated Deficit) $166,365,000 USD -5.4%
Stockholders' Equity Attributable to Parent $2,627,000 USD -4.6%
Liabilities and Equity $6,148,000 USD -1.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,618,000 USD -5.8%
Net Cash Provided by (Used in) Financing Activities $196,000 USD -86%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 10,608,734 shares 135%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,422,000 USD -823%
Deferred Tax Assets, Valuation Allowance $38,497,000 USD 4.9%
Deferred Tax Assets, Gross $38,497,000 USD 4.9%
Operating Lease, Liability $638,000 USD -39%
Depreciation $36,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $683,000 USD -42%
Property, Plant and Equipment, Gross $795,000 USD 0.25%
Operating Lease, Liability, Current $427,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $514,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $125,000 USD -75%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $45,000 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $44,000 USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $1,775,000 USD 5.8%
Operating Lease, Payments $375,000 USD 15%
Additional Paid in Capital $168,981,000 USD 5.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $12,000 USD -37%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $521,000 USD -30%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%